Capital Rotates to Niche Commodities and Vertical Tech Amid Asset Sales and AI Push

Investors are increasingly directing capital toward specialized commodities, niche biotechnology, and vertical software players in late 2026, driven by targeted government stimulus, strategic asset sales, and AI-driven platform expansions, according to recent corporate filings and market data.

Peabody Energy (BTU.US)

Peabody Energy shares surged approximately 15% after the US government invoked the Defense Production Act to inject nearly USD 700M into the domestic coal sector for facility upgrades. The company is capitalizing on the momentum, announcing in September 2026 the full redemption of its 3.250% convertible senior notes due 2028, according to a corporate statement.

Century Aluminum (CENX.US)

Century Aluminum shares rallied on news of a USD 500M funding agreement with the US Department of Energy. The company projected its Q3 2026 adjusted EBITDA to reach USD 335M, up from the previous quarter, as production ramps up at its expanded Mt. Holly facility and restarted Grundartangi lines.

Wheaton Precious Metals (WPM.US)

Wheaton Precious Metals shares have outperformed the broader mining sector this year following a record-setting Q2 2026. The streaming company reported quarterly revenue of USD 929M, prompting analysts at Scotiabank to reiterate an industry outperform rating with a USD 175.00 price target.

Chord Energy (CHRD.US)

Chord Energy stock trended higher as it agreed to divest its non-operated Marcellus assets to POSCO International Corporation for USD 550M. The deal, expected to close in Q4 2026, shifts the independent exploration company's focus entirely to the Williston basin, effectively increasing its oil weighting by roughly 4 to 5 percentage points, people familiar with the strategy said.

Arrow Electronics (ARW.US)

Arrow Electronics shares remained resilient amid a broader tech realignment. In September 2026, the company expanded its distribution agreement with Hewlett Packard Enterprise across North America and EMEA, while also advancing early evaluations for NXP's Ara240 edge AI accelerators to capture emerging edge computing demand.

System1 (SST.US)

System1 reported mixed trading after posting Q2 2026 revenue of USD 30.2M, down from the prior year, alongside a GAAP net loss of USD 15.3M. However, the company’s MapQuest service saw a resurgence, adding over 2M users to its iOS and Android platforms within a week in September, driven by the rollout of new agency-style AI products.

RELX (RENX.US)

RELX shares retreated nearly 3% in recent trading sessions despite strong underlying metrics. The information and analytics provider reported a 7% increase in Q2 2026 revenue and a 9% rise in operating profit, largely fueled by robust demand for its AI-driven analytical tools, according to earnings data.

Mereo BioPharma Group (MREO.US)

Mereo BioPharma Group stock gained momentum this quarter after securing an option and license agreement with Sentynl Therapeutics for alvelestat. Under the terms, Mereo is eligible for up to USD 435M in milestone payments and double-digit royalties, extending its cash runway through mid-2027.

Gold Resource Corporation (GORO.US)

Gold Resource Corporation saw heightened trading volatility following shareholder approval of its merger with Goldgroup Mining. The combined entity is accelerating exploration at the Don David gold mine, though the corporate restructuring renders the company ineligible for inclusion in the Russell 2000 index, index providers noted.

China SXT Pharmaceuticals (SXTC.US)

China SXT Pharmaceuticals shares remained under pressure despite aggressive corporate actions. The traditional Chinese medicine company executed a 1-for-80 reverse stock split in August 2026 to maintain its Nasdaq listing compliance, while concurrently attempting to integrate AI-supported analytics into its raw material supply chain.

This article does not constitute investment advice.